Anthracyclines
Summary
- Doxorubicin is the most widely used, and is commonly referred to as the “Red Devil” because of its eye-opening red pigment and cardiotoxicity: all of the anthracyclines can produce cardiotoxicity through free radical formation.
- It classically and commonly taught that doxorubicin produces irreversible (type I) cardiotoxicity (dilated cardiomyopathy) and trastuzumab produces reversible (type II) cardiotoxicity, but on deeper inspection each can do the opposite: aspects of anthracycline toxicity is reversible and some of the cardiotoxicity from trastuzumab can be irreversible.
- The cardio-pathology from anthracyclines is multifactorial, it’s helpful to consider that, in part, it stems from the same pathogenesis as with neoplastic cells: DNA damage and free radical-induced apoptosis.
- Trastuzumab cardiotoxicity likely involves antibody-mediated cytotoxicity or cell death directly related to its primary mechanism of action: the inhibition of HER2 signaling pathways.
- Daunorubicin was the first anthracycline to be used in the treatment of cancer.
- Mitoxantrone is an anthracycline analogue, (it’s actually an anthracenedione), which can cause blue discoloration to the nails, as well as the urine and sclera. Its primary dose-limiting side effect is myelosuppression.
Mechanisms
- The anthracyclines have multiple anti-neoplastic mechanisms of action, including DNA intercalation (wedging themselves between DNA base pairs to disrupt DNA structure); topoisomerase II inhibition; and free radical formation.
- DNA intercalation works as follows: the chemotherapy inserts itself in between base pairs,
forms bonds (adducts) with DNA bases (again, guanine is the most reactive), and deforms the winding geometry of the DNA double helix and produces torsional stress and topological injury to the double helix and disrupts further replication.
Miscellaneous
- Mitomycin, which acts via alkylation, and can cause pulmonary fibrosis.
- Bleomycin is an antitumor antibiotic that produces DNA breakage.
- Bleomycin forms single and double-strand breaks in DNA; specifically, it forms metallobleomycin complexes that break the 3’-4’ bonds of deoxyribose and, which results in cell cycle arrest in G2.
- A key side effect of this drug is pulmonary fibrosis, presenting with hemoptysis.